Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
暂无分享,去创建一个
Mary Feng | Yebin Tao | Matthew J Schipper | Elaine M Caoili | Theodore S Lawrence | E. Caoili | M. Schipper | T. Lawrence | M. Feng | E. Pollom | M. Stenmark | D. Wahl | Yebin Tao | Matthew H Stenmark | Erqi L Pollom | Daniel R Wahl
[1] V. Mazzaferro,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[2] Luigi Solbiati,et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? , 2007, Hepatology.
[3] W. Lau,et al. A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.
[4] J. Balter,et al. Stereotactic body radiation therapy for primary and metastatic liver tumors. , 2013, Translational oncology.
[5] S. Fan,et al. Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function: Implications for a Strategy of Salvage Transplantation , 2002, Annals of surgery.
[6] Andrea Bezjak,et al. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer. , 2013, International journal of radiation oncology, biology, physics.
[7] M. Bloomston,et al. Microwave Ablation for Hepatic Malignancies: A Multiinstitutional Analysis , 2014, Annals of surgery.
[8] Jan Nyman,et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries , 2006, Acta oncologica.
[9] R K Ten Haken,et al. The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. , 2001, International journal of radiation oncology, biology, physics.
[10] J. Vauthey,et al. Surgical Resection of High-Risk Hepatocellular Carcinoma: Patient Selection, Preoperative Considerations, and Operative Technique , 2010, Annals of Surgical Oncology.
[11] Zahra Kassam,et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] L. Mariani,et al. Radiofrequency Ablation of Small Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver Transplantation: A Prospective Study , 2004, Annals of surgery.
[13] Jong Hoon Kim,et al. Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma , 2013, PloS one.
[14] E. Kunieda,et al. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma , 2014, Journal of gastroenterology and hepatology.
[15] Dong Han Lee,et al. Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma , 2010, Journal of surgical oncology.
[16] Zhongxing Liao,et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] J. Palmgren,et al. Estimation of Multivariate Frailty Models Using Penalized Partial Likelihood , 2000, Biometrics.
[18] L. Gaspar,et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Yuman Fong,et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] H. Jang,et al. Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer , 2010, BMC Cancer.
[21] M. Pompili,et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[22] W. Helton,et al. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. , 2008, American journal of surgery.
[23] R J Little,et al. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches. , 2000, Annual review of public health.
[24] Marc L Kessler,et al. Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate. , 2005, Medical physics.
[25] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[26] Robert C. G. Martin,et al. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures , 2013, Journal of surgical oncology.
[27] Shinichi Shimizu,et al. Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination. , 2009, International journal of radiation oncology, biology, physics.
[28] Jacques Ferlay,et al. Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.